Effectiveness and safety of pembrolizumab for patients with advanced non-small cell lung cancer in real-world studies and randomized controlled trials: A systematic review and meta-analysis

Effectiveness and safety of pembrolizumab for patients with advanced non-small cell lung cancer in real-world studies and randomized controlled trials: A systematic review and meta-analysis

BackgroundSeveral randomized controlled trials (RCTs) have confirmed the favorable clinical benefit of pembrolizumab in advanced non-small cell lung cancer (NSCLC). However, considering the strict inclusion and exclusion criteria in clinical research, there are certain differences between patients i...

Full description

Bibliographic Details
Main Authors: Beibei Yang, Bing Wang, Yongbang Chen, Ning Wan, Fei Xie, Ning Yang, Liqing Lu, Weibin Xiao, Jin Yuan, Jian Li, Bo Xie, Bo Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
pembrolizumab
meta-analysis
non-small cell lung cancer
randomized controlled trials
real-world studies
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1044327/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1044327/full

Similar Items